| Side Effects Associated with YAZ / Yasmin / Ocella: Heart Attacks & Strokes Cardiac Arrhythmias Deep Vein Thrombosis Pulmonary Embolism Gallbladder Disease Sudden Death |
| Call for a FREE case evaluation: (713) 255-2055 |
| Yaz Litigation |
Yaz and Yasmin are two nearly identical birth control pills. It has now been shown
that women of all ages who use these drugs are at risk for heart attacks, strokes,
and deep vein thrombosis. YAZ and Yasmin are manufactured by the German
pharmaceutical giant, Bayer.
YAZ and Yasmin are the only two birth control pills on the market that contain a
new component known as drospirenone (DRSP). It has been shown that DRSP
disrupts heart rhythms, slows down blood flow, and causes blood clot formation.
Those clots lead to significant and potentially life-threatening heart problems and
other health issues. Studies have shown that women as young as 16 are at a 6.2
times higher risk of blood clots compared to women who do not use birth control
pills, the highest risk associated with any such drug.
In 2008, YAZ and Yasmin accounted for nearly a third of the birth control market
in the U.S., with sales approaching one billion dollars in 2007. The commercial
success of these drugs is largely due to Bayer’s aggressive marketing campaigns
that have since been called “deceptive” and “misleading” by the FDA. As a result
of the FDA action, Bayer ended up pulling the misleading ads and also reached an
agreement with the FDA and 27 state attorneys general to run a $20 million
advertising campaign to correct the misinformation from the pulled commercials..
A generic form of these drugs is now available and marketed under the name
Ocella.
that women of all ages who use these drugs are at risk for heart attacks, strokes,
and deep vein thrombosis. YAZ and Yasmin are manufactured by the German
pharmaceutical giant, Bayer.
YAZ and Yasmin are the only two birth control pills on the market that contain a
new component known as drospirenone (DRSP). It has been shown that DRSP
disrupts heart rhythms, slows down blood flow, and causes blood clot formation.
Those clots lead to significant and potentially life-threatening heart problems and
other health issues. Studies have shown that women as young as 16 are at a 6.2
times higher risk of blood clots compared to women who do not use birth control
pills, the highest risk associated with any such drug.
In 2008, YAZ and Yasmin accounted for nearly a third of the birth control market
in the U.S., with sales approaching one billion dollars in 2007. The commercial
success of these drugs is largely due to Bayer’s aggressive marketing campaigns
that have since been called “deceptive” and “misleading” by the FDA. As a result
of the FDA action, Bayer ended up pulling the misleading ads and also reached an
agreement with the FDA and 27 state attorneys general to run a $20 million
advertising campaign to correct the misinformation from the pulled commercials..
A generic form of these drugs is now available and marketed under the name
Ocella.
| "When companies place profits over the welfare of people we, as lawyers, should feel a special need to hold them accountable. accountability, positive change." Todd Kelly |
